Impact News +++ DocMorris Buy (DPA-AFX) +++ DOCMORRIS Aktie +6,12%

ELI LILLY Aktie

>ELI LILLY Aktienkurs

1115 EUR -0.1% (TradegateBSX)

Ask: 1118.6 EUR / 50 Stück

Bid: 1116 EUR / 50 Stück

Tagesumsatz: 171 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

ELI LILLY Aktie über LYNX handeln

Intraday

1 Jahr

>ELI LILLY Performance

1 Woche: +7,7%

1 Monat: +13,3%

3 Monate: +10,9%

6 Monate: +45,1%

1 Jahr: +57,0%

laufendes Jahr: +21,7%

>ELI LILLY Aktie

Profil:

Eli Lilly and Company is a global medicine company focused on discovering, developing, manufacturing, and marketing human pharmaceutical products. Eli Lilly and Company operates across major therapeutic areas including diabetes, obesity, oncology, im..
>Volltext..

Insiderhandel:

>ELI LILLY Kennzahlen

Aktien/ Unternehmen:

Analysten:

Bewertung:

Rentabilität:

Managementeffizenz:

>ELI LILLY Anleihen

>ELI LILLY Peer Group

Gesundheit, Neurologische Erkrankungen/ Schlaganfälle, Endokrine Erkrankungen (Hormonstörungen), Stoffwechselerkrankungen (Diabetes/ Adipositas), Onkologie/ Krebs- Behandlung
>Alle Branchen..

>ELI LILLY Chart & Kurs - NYSE

>ELI LILLY News

15.10.26 - 20:31	Big pharma stocks near all-time highs as tech selloff pushes investors toward safer bets (MarketWatch)
	Shares of AbbVie, Eli Lilly and Gilead Sciences are trading at or near record highs....

15.10.26 - 19:12	Stock Split Watch: Is Eli Lilly Next? (Fool)
	The stock has soared 25% in six months....

15.10.26 - 17:33	Micron Technology is lagging Eli Lilly, Berkshire Hathaway, and maybe soon Walmart in market cap (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

15.10.26 - 17:24	Eli Lilly′s Omvoh boosted by new ulcerative colitis, Crohn′s data (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

15.10.26 - 16:03	Lilly confirms date and conference call for third-quarter 2026 financial results announcement (PR Newswire)
	INDIANAPOLIS, Oct. 15, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its third-quarter 2026 financial results on October 29, 2026. Lilly will also conduct a conference call that day with the investment community and media to further detail the company's financial......

15.10.26 - 15:01	Eli Lilly Reports Positive One-Year Omvoh Data In Ulcerative Colitis, Crohn′s Disease (AFX)
	INDIANAPOLIS (dpa-AFX) - Thursday, Eli Lilly and Company (LLY) announced new data analyses showing that, at one year, patients with moderately to severely active ulcerative colitis and Crohn's dis......

15.10.26 - 14:07	Adlai Nortye To Enter Clinical Trial Collaborations With Lilly, Merck KGaA To Explore Cetuximab With AN4035 (AFX)
	INDIANAPOLIS (dpa-AFX) - Adlai Nortye Group (ANL) announced clinical trial collaboration and supply agreements with Eli Lilly and Company (LLY) and Merck KGaA (MRCG.DE, MRK.DE) for the anti-EGFR a......

15.10.26 - 13:55	Adlai To Enter Clinical Trial Collaborations With Lilly, Merck KGaA To Explore Cetuximab With AN4035 (AFX)
	INDIANAPOLIS (dpa-AFX) - Adlai Nortye Group (ANL) announced clinical trial collaboration and supply agreements with Eli Lilly and Company (LLY) and Merck KGaA (MRCG.DE, MRK.DE) for the anti-EGFR a......

14.10.26 - 17:01	Eli Lilly trotzt schwachem Gesamtmarkt: Pipeline-Fortschritte und Q3-Fantasie beflügeln die Aktie (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

14.10.26 - 14:06	Eli Lilly and Company Earnings Preview: What to Expect (Barchart)
	Um den gesamten Artikel unter newsbreak.com zu lesen, klicken Sie bitte auf die Überschrift...

14.10.26 - 12:54	Walmart-Offensive: Warum auch Novo und Eli Lilly profitieren (Der Aktionaer)
	Der Handelsriese Walmart erweitert im kommenden Jahr seine Krankenversicherung für Mitarbeiter. Über 250 verschreibungspflichtige Medikamente gibt es dann ohne Zuzahlung. Für Anleger im Gesundheitssektor ist das ein klares Signal für wachsende Nachfrage....

14.10.26 - 01:00	Here′s Why Eli Lilly (LLY) Fell More Than Broader Market (Zacks)
	Eli Lilly (LLY) reached $1 at the closing of the latest trading day, reflecting a -1.04% change compared to its last close....

13.10.26 - 23:24	Bristol Myers Squibb vs. Eli Lilly: Which Healthcare Stock Is a Better Buy in 2026? (Fool)
	Bristol Myers Squibb recovered to $7.1B in net income while Eli Lilly more than doubled profits to $20.6B, a stark contrast in momentum that reshapes the value-versus-growth debate....

13.10.26 - 19:30	GLP-1 Drugs May Slow Aging By Upto Four Years, Early Research Suggest (AFX)
	INDIANAPOLIS (dpa-AFX) - New research from Novo Nordisk A/S (NVO) and Eli Lilly and Company (LLY) suggests that their GLP-1 drugs may slow down certain biological signs of aging by two to four yea......

13.10.26 - 18:36	Prediction: Eli Lilly Could Have More Room to Grow Than Its Valuation Suggests (24/7 Wall St.)
	Eli Lilly trades at a premium multiple, yet its revenue growth dwarfs every major pharma peer by a wide margin. Whether that gap justifies buying shares near all-time highs depends on one critical assumption about Lilly's pipeline....

13.10.26 - 17:48	Johnson & Johnson Drops 5% as One-Time Charges Overshadow Raised Full-Year Outlook; Eli Lilly Dips, Pfizer Sits Out the Selloff (24/7 Wall St.)
	Johnson & Johnson (NYSE:JNJ) stock is at $249.55, down 5% early in the session. The company raised its full-year outlook in the same release that showed its reported profit falling under one-time charges. Meanwhile, Eli Lilly (NYSE:LLY) stock is at $1,174.46, down 0.7%, representing a much milder decline than Johnson & Johnson stock. At the […]...

13.10.26 - 16:24	Eli Lilly Reports Earnings on Oct. 29. Here′s Why the Retatrutide Story Matters More Than the Quarter. (Fool)
	Eli Lilly's next big growth driver could be bigger than Zepbound....

13.10.26 - 15:01	Abnehm-Revolution aus China?: Milliarden-Hammer bei Roche: Neue Wunderwaffe gegen Eli Lilly? (Wallstreet-Online)
	Roche investiert bis zu 1,16 Milliarden US-Dollar in eine neue Abnehmtherapie aus China. Damit verschärft der Pharmakonzern den Wettbewerb mit Eli Lilly und Novo Nordisk....

13.10.26 - 14:30	Prelude, Lilly Partner On Breast Cancer Combination Trial; Stock Up (AFX)
	INDIANAPOLIS (dpa-AFX) - Tuesday, Prelude Therapeutics Incorporated (PRLD) announced a clinical trial collaboration with Eli Lilly (LLY) to evaluate PRT13722 in combination with Verzenio (abemacic......

13.10.26 - 13:09	AbbVie, Eli Lilly among mega-cap healthcare stocks with A+ profitability grades (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Die Lehre, daß man kirchliche Bußstrafen in Strafen des Fegefeuers umwandeln könne, ist ein Unkraut, das augenscheinlich gesät wurde, als die Bischöfe schliefen. - Martin Luther

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram